According to a new study, oral treprostinil (Orenitram) could benefit patients with pulmonary arterial hypertension (PAH) who are currently dependent…
Articles by Magdalena Kegel
Anticoagulant use in pulmonary arterial hypertension (PAH) is surrounded by scientific disagreement. A perspective attempted to analyze the differences between…
Quality of life is an important measure of patient health and treatment effectiveness, but often overlooked in people with chronic thromboembolic pulmonary…
Wall shear stress in the main pulmonary artery was found to be associated with worse hemodynamic parameters, as well as…
Elderly people at increased risk of pulmonary hypertension (PH) are increasingly also being diagnosed with pulmonary arterial hypertension (PAH). Diagnosis…
Researchers from Chungbuk National University, Korea, found that ranolazine (Ranexa), a drug used to treat coronary heart disease, effectively reduced…
Blocking the enzyme sphingosine kinase 1 (SK1) reduced right ventricle enlargement in a mouse model of pulmonary arterial hypertension (PAH),…
A study from Johns Hopkins School of Medicine showed that a cellular ion transporter might contribute to the increased…
A study recently published in the journal European Respiratory Review reported the case of a man with pulmonary…
Iloprost, an inhaled solution, is approved for the management of pulmonary arterial hypertension (PAH) in several countries, including the United…
The cardiac hormone known as atrial natriuretic peptide (ANP) controls blood pressure both throughout the body and in the lungs.
Patients with systemic lupus erythematosus who develop pulmonary arterial hypertension (PAH) have a poorer prognosis, according to a review from the…